Latest News Archive
Please select Category, Year, and then Month to display items
11 September 2024
|
Story Anthony Mthembu
|
Photo Anthony Mthembu and Chelsea Carolus
From the left: Geraldine Lengau, Senior Officer in the Unit for Institutional Change at the UFS; and Oratile Reina, West College Prime.
As part of the initiatives lined up for College Week, the student leaders of West College at the University of the Free State (UFS) hosted a dialogue that primarily focused on discussing social justice as a value of Vision 130. The dialogue was held at Outeniqua Residence on 3 September 2024 and was well attended by students within West College.
According to Oratile Reina, West College Prime, “the motivation for the dialogue was to prepare newly elected leaders and our college community to align their efforts with Vision 130 – a vision that aims to create a more inclusive, equitable, and socially just environment on campus”. As such, she highlights that the dialogue was an opportunity for leaders to discuss practical strategies for implementing these values in their respective spaces, and to encourage those in West College to become better citizens inside and outside the university.
A conversation on social justice
The dialogue was facilitated by Geraldine Lengau, Senior Officer in the Unit for Institutional Change and Social Justice at the UFS. Lengau touched on several aspects pertaining to the topic of discussion. Firstly, she allowed the audience to give their definition of social justice, especially as students within the institution. In addition, she went on to talk to the audience about sexual assault in the context of social justice. In this instance, Lengau gauged whether the students knew which processes to follow in the event of a sexual assault incident, and whether they were acquainted with the UFS Sexual Harassment, Sexual Misconduct, and Sexual Violence Policy. Furthermore, the audience was given the opportunity to outline what social justice looks like to them in the spaces they occupy, including in their respective faculties, the sports they play, and the leadership structures they form part of. “I was encouraged to see that students take their right to a socially just university in very high regard, and that they were willing to break it down from what Vision 130 proposes, in order to align it with their common understanding,” said Lengau.
As the dialogue concluded, the audience signed a pledge committing to uphold the values of Vision 130. According to Reina, “The pledge represents a promise to take concrete steps towards fostering an inclusive and equitable campus culture. By signing the pledge, the leaders are not only agreeing to embody these principles in their leadership roles but are also holding themselves accountable to their peers and the broader university community.”
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology